- Home
- BWB vs CRMD Comparison
BWB vs CRMD Comparison
Compare BWB & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BWB | CRMD |
|---|---|---|
| Founded | 2005 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 515.6M | 605.9M |
| IPO Year | 2018 | 2010 |
Fundamental Metrics
Financial Performance| Metric | BWB | CRMD |
|---|---|---|
| Price | $19.21 | $7.36 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | ★ $22.33 | $15.29 |
| AVG Volume (30 Days) | 90.1K | ★ 2.2M |
| Earning Date | 01-27-2026 | 03-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 44.66 | N/A |
| EPS | 1.49 | ★ 2.25 |
| Revenue | $137,303,000.00 | ★ $214,303,672.00 |
| Revenue This Year | $22.20 | $631.55 |
| Revenue Next Year | $14.52 | $13.99 |
| P/E Ratio | $12.88 | ★ $3.26 |
| Revenue Growth | 29.49 | ★ 1647.67 |
| 52 Week Low | $11.93 | $5.60 |
| 52 Week High | $20.30 | $17.43 |
Technical Indicators
Market Signals| Indicator | BWB | CRMD |
|---|---|---|
| Relative Strength Index (RSI) | 54.08 | 38.12 |
| Support Level | $18.89 | $7.29 |
| Resistance Level | $20.30 | $7.85 |
| Average True Range (ATR) | 0.71 | 0.37 |
| MACD | -0.05 | 0.09 |
| Stochastic Oscillator | 47.14 | 4.03 |
Price Performance
Historical ComparisonAbout BWB Bridgewater Bancshares Inc.
Bridgewater Bancshares Inc is a financial holding company. Through its subsidiary, it offers various personal and commercial banking products and services such as savings accounts, certificates of deposits, money transfer services, digital wallets, credit and debit cards, safe deposit lockers, different types of loans and advances, commercial deposit accounts, treasury management, and others. The company principally focuses on catering to commercial clients, offering them a suite of loan and deposit products. Geographically, it mainly operates in the Twin Cities Metropolitan Statistical Area in the United States.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.